Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $99,850 | 39 | 93.8% |
| Travel and Lodging | $4,817 | 22 | 4.5% |
| Food and Beverage | $1,805 | 41 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Travere Therapeutics, Inc. | $47,507 | 32 | $0 (2021) |
| GlaxoSmithKline, LLC. | $35,124 | 30 | $0 (2021) |
| Retrophin, Inc. | $15,225 | 27 | $0 (2019) |
| Alexion Pharmaceuticals, Inc. | $7,250 | 2 | $0 (2020) |
| VERTEX PHARMACEUTICALS INCORPORATED | $1,295 | 8 | $0 (2019) |
| Amgen Inc. | $37.91 | 1 | $0 (2017) |
| Genentech USA, Inc. | $31.24 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $28,983 | 13 | Travere Therapeutics, Inc. ($19,783) |
| 2020 | $50,457 | 40 | Travere Therapeutics, Inc. ($27,724) |
| 2019 | $20,482 | 36 | Retrophin, Inc. ($15,137) |
| 2018 | $16.58 | 1 | Genentech USA, Inc. ($16.58) |
| 2017 | $6,533 | 12 | GlaxoSmithKline, LLC. ($6,393) |
All Payment Transactions
102 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/20/2021 | Travere Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| 09/15/2021 | Travere Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $800.00 | General |
| 06/11/2021 | Travere Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,200.00 | General |
| 06/04/2021 | Travere Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $6,000.00 | General |
| 06/01/2021 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Consulting Fee | Cash or cash equivalent | $690.00 | General |
| Category: IMMUNOLOGY | ||||||
| 05/18/2021 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Consulting Fee | Cash or cash equivalent | $5,980.00 | General |
| Category: IMMUNOLOGY | ||||||
| 04/13/2021 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Consulting Fee | Cash or cash equivalent | $1,840.00 | General |
| Category: IMMUNOLOGY | ||||||
| 02/18/2021 | Travere Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,000.00 | General |
| 02/10/2021 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $690.00 | General |
| 01/21/2021 | Travere Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| 01/21/2021 | Travere Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $800.00 | General |
| 01/21/2021 | Travere Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| 01/13/2021 | Travere Therapeutics, Inc. | — | Food and Beverage | Cash or cash equivalent | $83.01 | General |
| 12/17/2020 | Travere Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,400.00 | General |
| 12/14/2020 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $7,130.00 | General |
| 10/31/2020 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Consulting Fee | Cash or cash equivalent | $1,840.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2020 | Travere Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,000.00 | General |
| 10/08/2020 | Travere Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,800.00 | General |
| 10/08/2020 | Travere Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| 09/21/2020 | Travere Therapeutics, Inc. | — | Food and Beverage | Cash or cash equivalent | $69.99 | General |
| 07/23/2020 | Travere Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| 07/23/2020 | Travere Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| 06/26/2020 | Alexion Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,750.00 | General |
| 05/05/2020 | Travere Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| 05/05/2020 | Travere Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $800.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 4 | 80 | 102 | $44,238 | $9,507 |
| 2020 | 9 | 265 | 483 | $207,453 | $41,167 |
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 24 | 35 | $7,700 | $3,415 | 44.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 16 | 22 | $7,590 | $2,799 | 36.9% |
| 50200 | Needle biopsy of kidney, accessed through the skin | Facility | 2021 | 11 | 11 | $19,778 | $1,200 | 6.1% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 16 | 21 | $7,350 | $1,148 | 15.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 13 | 13 | $1,820 | $945.28 | 51.9% |
| 90999 | Inpatient or outpatient dialysis services | Facility | 2020 | 35 | 120 | $90,000 | $9,268 | 10.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 55 | 83 | $18,385 | $7,332 | 39.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 36 | 51 | $17,455 | $5,418 | 31.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 28 | 54 | $9,769 | $4,871 | 49.9% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2020 | 34 | 64 | $22,400 | $4,072 | 18.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 23 | 56 | $7,546 | $3,503 | 46.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 13 | 13 | $4,225 | $2,281 | 54.0% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 11 | 11 | $5,255 | $1,838 | 35.0% |
| 50200 | Needle biopsy of kidney, accessed through the skin | Facility | 2020 | 15 | 16 | $28,768 | $1,732 | 6.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 15 | 15 | $3,650 | $852.01 | 23.3% |
About Dr. Jonathan Hogan, MD
Dr. Jonathan Hogan, MD is a Nephrology healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1366644791.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Hogan, MD has received a total of $106,471 in payments from pharmaceutical and medical device companies, with $28,983 received in 2021. These payments were reported across 102 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($99,850).
As a Medicare-enrolled provider, Hogan has provided services to 345 Medicare beneficiaries, totaling 585 services with total Medicare billing of $50,674. Data is available for 2 years (2020–2021), covering 15 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Other Specialties Nephrology
- Location Philadelphia, PA
- Active Since 06/05/2007
- Last Updated 03/18/2014
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1366644791
Products in Payments
- BENLYSTA (Biological) $10,680
- Ultomiris (Drug) $4,500
- Rituxan (Biological) $31.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Philadelphia
Dr. Rakesh Gulati, Md, MD
Nephrology — Payments: $602,663
Raymond Townsend, Md, MD
Nephrology — Payments: $348,680
Ellie Kelepouris, Md, MD
Nephrology — Payments: $289,837
Katalin Susztak, Md, MD
Nephrology — Payments: $164,350
Debbie Cohen Stein, Md, MD
Nephrology — Payments: $92,545
Laura Dember, M.d, M.D
Nephrology — Payments: $78,703